Cytokinetics
CYTK
HK$287.52
Share price
-1.48%
Change (1 day)
-37.70%
Change (1 year)
Categories
Cytokinetics (CYTK) - Total debt
Total debt on the balance sheet as of March 2025 : HK$6.20 Billion
According to Cytokinetics 's latest financial reports the company's total debt is HK$6.20 Billion. A company’s total debt is the sum of all current and non-current debts.
Cytokinetics - Total debt on balance sheet (from 2003 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | HK$6.12 B | 3.73% |
| 2023-12-31 | HK$5.90 B | 0.69% |
| 2022-12-31 | HK$5.86 B | 178.52% |
| 2021-12-31 | HK$2.10 B | 95.42% |
| 2020-12-31 | HK$1.07 B | 1.64% |
| 2019-12-31 | HK$1.05 B | 213.37% |
| 2018-12-31 | HK$0.33 B | 36.21% |
| 2017-12-31 | HK$0.24 B | 7.15% |
| 2016-12-31 | HK$0.23 B | 104.22% |
| 2015-12-31 | HK$0.11 B | |
| 2012-12-31 | N/A | -100% |
| 2011-12-31 | HK$1.18 M | -84.6% |
| 2010-12-31 | HK$7.66 M | -92.28% |
| 2009-12-31 | HK$99.26 M | 176.84% |
| 2008-12-31 | HK$35.85 M | -47.08% |
| 2007-12-31 | HK$67.74 M | -19.61% |
| 2006-12-31 | HK$84.26 M | 16.1% |
| 2005-12-31 | HK$72.58 M | -10.98% |
| 2004-12-31 | HK$81.54 M | 4.33% |
| 2003-12-31 | HK$78.15 M | 5.58% |
| 2002-12-31 | HK$74.02 M | 169.31% |
| 2001-12-31 | HK$27.48 M | 226.62% |
| 2000-12-31 | HK$8.41 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | HK$34.91 M | -99.44% | 🇺🇸 USA |
 Trevena TRVN | HK$0.29 B | -95.25% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | HK$1.53 B | -75.23% | 🇺🇸 USA |
 Amgen AMGN | HK$450.39 B | 7,153.73% | 🇺🇸 USA |
 Array Technologies ARRY | HK$5.32 B | -14.17% | 🇺🇸 USA |